Allergy Therapeutics

Allergy Therapeutics is a commercial biopharmaceutical company developing, manufacturing and selling immunotherapies that address the underlying immune cause of allergic disease.

Its marketed products, sold across Europe, include short-course subcutaneous treatments for pollen and other respiratory allergies, combining modified allergens with adjuvants to strengthen the immune response.

The company is also developing a virus-like particle-based immunotherapy for peanut allergy and manufactures its products at its own facility.